Literature DB >> 22298049

Spectrum of urodynamic abnormalities and renal function changes in adult men with non-neurogenic urinary retention.

Jane M Lewis1, Subbarao V Yalla, Kate E Stanitski, Maryrose P Sullivan.   

Abstract

INTRODUCTION: The purpose of this study was to identify abnormalities in bladder and renal function in men with urinary retention presumed to be due to BPH.
METHODS: In this retrospective analysis, urodynamic studies (UDS) and renal function were evaluated. Bladder contractility and compliance and the severity of bladder outlet obstruction (BOO) were determined from urodynamics. Renal function (BUN, creatine, eGFR) was assessed prior to retention, at the time of presentation and after urodynamic evaluation.
RESULTS: Of 87 patients with evaluable UDS, 48% did not demonstrate detrusor activity during testing while 52% showed some detrusor contractile activity. Of these, 23% did not have BOO. Diminished bladder compliance was detected in 56%. In the entire cohort, BUN, serum creatinine, and eGFR were significantly changed during retention but were restored after catheterization. In older patients (>75 years), BUN and creatinine during retention were significantly higher, and eGFR was significantly lower compared to younger patients, but renal function after catheterization was not different between age groups. No significant correlations were found between renal function measurements and bladder compliance or age.
CONCLUSION: The urodynamic spectrum in men with urinary retention ranged from detrusor acontractility to varied degrees of contractility associated with outlet obstruction spanning from equivocal to severe. Moreover, prompt relief of retention restores renal function to baseline levels, regardless of age. This study indicates that prostatic obstruction may not be the only cause of urinary retention in adult men presumed to have BPH and illustrates the value of urodynamic assessment prior to potentially failure-prone surgical interventions. Published 2012 Wiley Periodicals, Inc. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2012        PMID: 22298049     DOI: 10.1002/nau.22196

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  5 in total

Review 1.  The effect of bladder catheterization on the incidence of urinary tract infection in laboring women with epidural analgesia: a meta-analysis of randomized controlled trials.

Authors:  Meixuan Li; Xin Xing; Liang Yao; Xiaoqin Wang; Wenbo He; Meng Wang; Huijuan Li; Yangqin Xun; Peijing Yan; Xu Hui; Xinmin Yang; Kehu Yang
Journal:  Int Urogynecol J       Date:  2019-03-05       Impact factor: 2.894

Review 2.  Postpartum urinary retention: a systematic review of adverse effects and management.

Authors:  F E M Mulder; R A Hakvoort; M A Schoffelmeer; J Limpens; J A M Van der Post; J P W R Roovers
Journal:  Int Urogynecol J       Date:  2014-05-20       Impact factor: 2.894

3.  Comparison of clean intermittent and transurethral indwelling catheterization for the treatment of overt urinary retention after vaginal delivery: a multicentre randomized controlled clinical trial.

Authors:  Femke E M Mulder; Robert A Hakvoort; Jan P de Bruin; Joris A M van der Post; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2017-08-30       Impact factor: 2.894

4.  Accuracy of postvoid residual volumes after vaginal delivery: a prospective equivalence study to compare an automatic scanning device with transurethral catheterization.

Authors:  Femke E M Mulder; Sytske van der Velde; Fraukje Pol; Marjolein Bos; Jules Schagen van Leeuwen; Viviane Dietz; Robert A Hakvoort; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2018-06-27       Impact factor: 2.894

5.  Delivery-related risk factors for covert postpartum urinary retention after vaginal delivery.

Authors:  Femke E M Mulder; Katrien Oude Rengerink; Joris A M van der Post; Robert A Hakvoort; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2015-07-30       Impact factor: 2.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.